News

Canada Approves Thermi RF for Treatment of Dermal Laxity

Image courtesy of Barry DiBernardo

Health Canada has issued a medical device license to Thermi to market its Thermi RF system for the treatment of dermal laxity, making it the first device approved for this indication in the country.

The temperature-controlled radiofrequency (RF) platform technology, which is used for ThermiTight, ThermiSmooth and ThermiRase procedures, was first approved in Canada in 2015 for electrocoagulation of soft tissue and nerve ablation.

Restoration Robotics Launches Master Class for ARTAS Robotic Hair Restoration

Pattern Guide for Hair Transplantation

Restoration Robotics has launched a new Master Class Series for its ARTAS Robotic Hair Restoration System to train physicians on best practices and the most up-to-date techniques. The Master Class Series includes live demonstrations, hands-on training and covers multiple topics, such as technical aspects of robotic surgery, overcoming challenges of hairline design, and donor and recipient site planning.

CareCredit Expands To Spa Market

Patient-financing company CareCredit is expanding its services into the day spa and medical spa markets. As part of this new program, CareCredit has partnered with the American Med Spa Association and the Spa Industry Association to help spa industry professionals make their services more accessible to clients by offering financing and also by expanding their potential client bases to CareCredit’s 11 million existing cardholders.

InMode Introduces EmbraceRF for Facial Contouring

FaceTite + Morpheus8 for Facial Contouring

InMode Aesthetic Solutions has launched EmbraceRF, a minimally invasive facial contouring treatment that combines two of the company’s proprietary technologies: FaceTite and Morpheus8. FaceTite features an internal probe that is placed in the subcutaneous adipose layer and an external probe that makes contact with the skin. Electrodes apply RF energy to all tissue between the probes. The Morpheus8 is applied externally to mold the fat subdermally.

Nodule Formation Following HA Filler Treatment

Lip Injections

Hyaluronic acid filler injections can cause persistent and recurring nodules that require combination therapies to clear. And products with a high degree of cross-linking may be more difficult to disintegrate with hyaluronidase. Authors Meredith L. Orseth MD, Nicole Lee MD, Omer Ibrahim MD, Kenneth A. Arndt MD, and Michael Kaminer MD, published two case studies of patients who experienced nodule formation after treatment with an HA filler (Journal of Drugs in Dermatology, May 2018).

1060nm Laser Effective for Hair Removal on All Skin Types

Lumenis Infinity

A recent study of Lumenis’ Inifinity 1,060nm diode laser revealed that the device is effective and offers a good safety profile for laser hair removal on all skin types. Authors Edward V. Ross, MD, Omar A. Ibrahimi, MD, and Suzanne Kilmer, MD, performed an open‐label, prospective, multi‐center study of 42 adult patients of varying skin types with dark brown or black hairs at the treatment site. Subjects underwent one of two treatment regimens. Sixteen patients had six treatments, spaced four to six weeks apart, using a chilled sapphire tip handpiece.

Silvernail Named CFO of Evolus

Evolus Prepares for Botulinum Toxin Launch

Lauren Silvernail, former chief financial officer (CFO) and chief business officer at Revance Therapeutics, is now the CFO and executive vice president of corporate development at Evolus. Prior to her time at Revance, Silvernail served as CFO and VP of corporate development at ISTA Pharmaceuticals. She joins the company as it works towards approval of its prabotulinumtoxinA injectable (DWP-450) for the treatment of moderate-to-severe glabellar lines.